Retatrutide

Triple GLP-1/GIP/glucagon agonist — the frontier of metabolic research.

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. The glucagon receptor component adds a thermogenic dimension absent in dual agonists, driving energy expenditure alongside reduced intake. Research explores novel mechanisms for severe obesity, NAFLD, and cardiometabolic syndrome.

Research Applications

• Triple GLP-1/GIP/glucagon agonism
• Thermogenic energy expenditure
• NAFLD/NASH research applications
• Superior weight reduction modeling
• Cardiometabolic syndrome studies